Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn's disease (REMODEL-CD): study protocol for a multicentre, open-label, pragmatic clinical trial in the USA.
Phillip Paul MinarRuben J ColmanNanhua ZhangTomoyuki MizunoAlexander A VinksPublished in: BMJ open (2024)
NCT05660746.